{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-25-016885","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.123697+00:00","generated_at":"2026-05-16T18:48:41.017890+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Alzamend Neuro director Andrew H. Woo, M.D., Ph.D. passed away on Nov. 14, 2025","bullets":["Andrew H. Woo served as a director since the company's IPO in June 2021.","William B. Horne, Chairman, expressed condolences; Woo is succeeded by no replacement yet.","No other material events reported; financial statements not affected."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-25-016885","json":"https://secwatch.observer/filing/0001214659-25-016885.json","markdown":"https://secwatch.observer/filing/0001214659-25-016885.md","text":"https://secwatch.observer/filing/0001214659-25-016885.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465925016885/0001214659-25-016885-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465925016885/x11172508k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:48:41.017890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}